Genome Instability & Disease (GIAD) publishes high-quality, peer-reviewed original research papers, short communications, and review articles on the molecular mechanisms underlying genome stability maintenance and genome instability-associated human diseases and therapeutic applications. In particular, GIAD publishes novel data regarding the regulatory mechanisms of genome stability, including epigenetic and post-translational modifications, and the DNA damage response and its association with the inheritance of mutations that contribute to genetic disorders, neurodegenerative diseases, cancer, and ageing.

Topics may include, but are not limited to:

§ Cell cycle checkpoints

§ DNA damage response

§ Post-translational modifications

§ Epigenetic regulation

§ Radio/chemotherapeutic sensitization

§ Genome stability genes as a therapeutic target

§ Genome instability-associated diseases

§ Neurodegenerative diseases

§ DNA damage-based therapy and drug discovery

GIAD publishes one volume per year, consisting of six regular issues. All submissions undergo a double-blind peer review process.

The journal will be officially launched in January 2020 but submissions are very much welcomed from now on. The accepted articles will be published as online first before January 2020.

Journal information

Editor-in-Chief
  • Wei-Guo Zhu,
  • Marco Foiani
Publishing model
Hybrid. Learn about publishing OA with us

Latest articles

This journal has 8 open access articles

Journal updates

  • NEW Journal starting in 2020

    Enjoy free access to all articles during 2020 and 2021 - an introductory offer to ensure high readership. Submit your paper now for maximum visibility! With Online First we offer rapid publication once your paper has been accepted.

    Submit here

View all updates
You have access to our articles

Subscribe

eJournal
$95.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles
  • Downloadable in PDF format
  • Subscription expires 12/31/2020

About this journal

Electronic ISSN
2524-7662
Abstracted and indexed in
  1. CNKI
  2. Dimensions
  3. EBSCO Discovery Service
  4. Google Scholar
  5. Institute of Scientific and Technical Information of China
  6. Meta
  7. Naver
  8. OCLC WorldCat Discovery Service
  9. ProQuest-ExLibris Primo
  10. ProQuest-ExLibris Summon
  11. TD Net Discovery Service
Copyright information

Rights and permissions

Springer policies

© Shenzhen University School of Medicine; Fondazione Istituto FIRC di Oncologia Molecolare